Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy-Reference-Cited by-同舟云学术

Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy

Published:2006 Issue:5 Volume:107 Page:1008-1013
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Alimena Giuliana,Breccia Massimo,Latagliata Roberto,Carmosino Ida,Russo Eleonora,Biondo Francesca,Diverio Daniela,Mancini Marco,Nanni Mauro,Mandelli Franco

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. The Biology of Chronic Myeloid Leukemia

2. Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome–positive chronic-phase chronic myeloid leukemia after failure of interferon-α

3. Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate

4. Sudden onset of the blastic phase of chronic myelogenous leukemia

5. Early Blastic Transformation Following Complete Cytogenetic Response in a Pediatric Chronic Myeloid Leukemia Patient Treated With Imatinib Mesylate

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sudden Blast Crisis After Excellent Initial Response in Chronic Myeloid Leukemia;Cureus;2021-09-28

2. Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors;Cancer Medicine;2021-05-14

3. Management of Chronic Myeloid Leukemia in Advanced Phase;Frontiers in Oncology;2019-10-25

4. Synthesis, Biological Activities and Docking Studies of Novel 4-(Arylaminomethyl)benzamide Derivatives as Potential Tyrosine Kinase Inhibitors;Molecules;2019-09-30

5. T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia;Leukemia & Lymphoma;2019-01-16